AzTrials
AzTrials

Disabled PeoplePHVNCT02735005

Determining the Needs of Aging People With Disabilities

A study testing SMAF assessment in people with Disabled People and Aging, run by Centre Hospitalier Annecy Genevois at 30 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Heterogeneous modalities of aging lead to describe three categories of elderly patients: 1-healthy without frailty, 2- healthy with frailty, 3- patients with chronic disease(s) and frailty. Frail people have a high risk of losing functional independence and as a consequence they require more help for day to day life. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Disabled People, Aging, Mental Handicap
What is being tested?
SMAF assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
741 participants
Where
30 sitesFrance
Study dates
Aug 2015to 31 Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult 40 years or older
  • must need help allocated by government social health services (Committee on Rights and Autonomy of Disabled People = french CDAPH)
  • must live
  • either in dedicated units or specialized homes (french medicalized care homes, or dedicated community homes)
  • or at home but working in specialized dedicated centers (So called french Etablissement et Service d'Aide par le Travail) or requiring intervention of specialized services (Support Service for Social Life or Medical-Social Support Service for Disabled Adults)

Who cannot join

  • patient or patient's legal guardian opposed to participate

Trial locations and contacts

30 sites in 1 country.

30 sites in 1 country

France30 sites
  • FAM du Moulin

    Allinges, 74500

  • APF - SAVS Annecy

    Annecy, 74000

  • ESAT "Ateliers de Novel"

    Annecy, 74000

  • FAM Le Goëland

    Annecy, 74000

  • SAVS - Association Départementale des Infirmes Moteurs Cérébraux

    Annecy, 74000

  • Savs Archim'Aide

    Annecy, 74000

  • Savs Espoir 74-Oxygene

    Annecy, 74000

  • ESAT Bellegarde Industries

    Bellegarde, 01200

  • EHPAD Maison de Famille du Genevois

    Collonges-sous-Salève, 74160

  • ESAT Ferme de Chosal

    Copponex, 74350

  • ADMR Haute-Savoie - SSIAD/SAD

    Cran-Gevrier, 74900

  • ADTP Site de Cran-Gevrier (Entreprises Adaptées)

    Cran-Gevrier, 74960

  • Esat Messidor

    Cran-Gevrier, 74960

  • ESAT Antenne du pays de Gex

    Ferney-Voltaire, 01210

  • Foyer des Roseaux and FAM des Iris

    La Balme-de-Sillingy, 74330

  • EHPAD La Bartavelle

    Meythet, 74960

  • FAM Le Goëland

    Meythet, 74960

  • FAM Résidence Leirens - Armée du Salut Monnetier Mornex

    Monnetier, 74560

  • SAVS Association Vivre en Ville 01

    Ornex, 01210

  • ESAT L'Arcalod

    Rumilly, 74150

  • Association ECLAT Pays de Gex

    Saint-Genis, 01630

  • FAM Pré la Tour

    Saint-Jean, 01630

  • ESAT Le Central

    Seynod, 74600

  • ESAT Le Semnoz

    Seynod, 74600

  • SAMSAH Le Fil d'Ariane

    Seynod, 74600

  • SAMSAH Le Bilboquet

    Seynod, 74960

  • ESAT Myriade

    Thônes, 74230

  • Centre Arthur Lavy - FAM Le Cristal

    Thorens-Glières, 74570

  • Centre Arthur Lavy - MAS l'Opaline

    Thorens-Glières, 74570

  • Association "Nous aussi" - Foyer d'hébergement - SATTHAV

    Vétraz-Monthoux, 74106

Other trials in France

About this study

Official title: Epidemiology of Aging of People With Disabilities - Gerontological Sector "Rumilly-Annecy-Saint-Julien-Pays de Gex-Bellegarde" : Description of the Population in an Attempt to Identify Ways to Implement to Meet the Needs in Aging

Heterogeneous modalities of aging lead to describe three categories of elderly patients: 1-healthy without frailty, 2- healthy with frailty, 3- patients with chronic disease(s) and frailty. Frail people have a high risk of losing functional independence and as a consequence they require more help for day to day life. It is known in elderly that physical activities, nutrition, social environment are important to maintain functional independence.

For patients with disabilities, less is known about the occurence of dependance with aging. That is of growing importance because life expectancy of disabled patients has increased a lot during last decades, and because caregivers, often parents, also become elderly and frail.

Read more

So the investigators will require tools to anticipate prevention and supportive needs for this specific population.

The goal of this study is to evaluate if the participants (disabled patients over 40 years old) of a well-defined region in the south-east of France (400000 inhabitants), and to assess their needs, using the Functional Autonomy Measurement System (SMAF) developed for assessment of the elderly, by Rejean Hebert \& Nicole Dubuc's team in Sherbrooke University (Quebec/Canada).

Being tested
SMAF assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SMAF assessmentOther

    After written information and non opposition expression, each enrolled patient will be assessed with the Functional Autonomy Measurement System (SMAF) tool during a 1 hour interview.

    The French authority has considered this study as an interventional study with minimal risk because we use a tool (SMAF) that was not developped nor validated in this specific population (disabled people older than 40y). The SMAF assessment is not made in routine in this specific population (ID RCB : 2015-A00642-47)

Study groups in NCT02735005
Study groupRoleWhat they receive
SMAF assessmentExperimentalFace to face interview for the Functional Autonomy Measurement System (SMAF) tool questionnaire For disabled patients living at home, the Social SMAF questionnaire is used in addition. Data related to care consumption of each enrolled patients are collected too.
Receives: Other: SMAF assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Needs in supports for aging disabled patients

    classification into one of the fourteen homogenous profiles of the Fonctional Autonomy Measurement System (SMAF) tool. The SMAF tool is a software based on responses of 29 predefined items on incapacities (with 4 modalities of response for each) and care and ressources used by interviewed people. The social SMAF tool adds 6 supplementary items (also with 4 modalities of response for each).

    Predefined algorithms defined for not disabled elderly people leads to classification into 14 homogeneous profiles. Progression's modalities of elderly from one profile to another is well known.

    The goal of this study is to determine if the same tool could be used for a younger disabled population, and if not, we want to build other algorithms dedicated to this aging disabled population. That's why this study is performed in collaboration with the Sherbrooke's team who designed the SMAF tool.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Apr 2016 (estimated)
  2. Study startAug 2015
  3. Primary completion26 Sep 2016
  4. Study completion31 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
741 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02735005
Sponsor's protocol ID
2015-A00642-47
Acronym
PHV
Status last verified
Apr 2018
First submitted
24 Mar 2016
Last updated
18 Jun 2019
Results posted
No
Data monitoring committee
Yes

Publications

  • Ahmed N, Mandel R, Fain MJ. Frailty: an emerging geriatric syndrome. Am J Med. 2007 Sep;120(9):748-53. doi: 10.1016/j.amjmed.2006.10.018.

    PubMed 17765039
  • Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.

    PubMed 11253156
  • Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63. doi: 10.1093/gerona/59.3.m255.

    PubMed 15031310
  • Rubenstein LZ, Josephson KR, Wieland GD, English PA, Sayre JA, Kane RL. Effectiveness of a geriatric evaluation unit. A randomized clinical trial. N Engl J Med. 1984 Dec 27;311(26):1664-70. doi: 10.1056/NEJM198412273112604.

    PubMed 6390207
  • Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet. 1993 Oct 23;342(8878):1032-6. doi: 10.1016/0140-6736(93)92884-v.

    PubMed 8105269
  • Stuck AE, Egger M, Hammer A, Minder CE, Beck JC. Home visits to prevent nursing home admission and functional decline in elderly people: systematic review and meta-regression analysis. JAMA. 2002 Feb 27;287(8):1022-8. doi: 10.1001/jama.287.8.1022.

    PubMed 11866651
  • Carlsen WR, Galluzzi KE, Forman LF, Cavalieri TA. Comprehensive geriatric assessment: applications for community-residing, elderly people with mental retardation/developmental disabilities. Ment Retard. 1994 Oct;32(5):334-40.

    PubMed 7984118
  • Pinsonnault E, Dubuc N, Desrosiers J, Delli-Colli N, Hebert R. Validation study of a social functioning scale: The social-SMAF (social-Functional Autonomy Measurement System). Arch Gerontol Geriatr. 2009 Jan-Feb;48(1):40-4. doi: 10.1016/j.archger.2007.10.001. Epub 2007 Dec 3.

    PubMed 18061289
  • Dubuc N, Hebert R, Desrosiers J, Buteau M, Trottier L. Disability-based classification system for older people in integrated long-term care services: the Iso-SMAF profiles. Arch Gerontol Geriatr. 2006 Mar-Apr;42(2):191-206. doi: 10.1016/j.archger.2005.07.001. Epub 2005 Aug 25.

    PubMed 16125809
  • Gervais P, Hebert R, Lamontagne J, Tousignant M. [Implementation of functional autonomy measurement system: barriers and facilitators in PISE-Dordogne project]. Geriatr Psychol Neuropsychiatr Vieil. 2011 Dec;9(4):417-28. doi: 10.1684/pnv.2011.0306. French.

    PubMed 22182818
  • Vellas BJ, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ, Garry PJ. One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc. 1997 Jun;45(6):735-8. doi: 10.1111/j.1532-5415.1997.tb01479.x.

    PubMed 9180669

Questions about this trial

What is this clinical trial studying?

A study testing SMAF assessment in people with Disabled People and Aging, run by Centre Hospitalier Annecy Genevois at 30 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 30 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Needs in supports for aging disabled patients (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02735005, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in